Benefit of antibiotic therapy on pouchitis after ileal pouch anal anastomosis: A systematic review and meta-analysis of clinical trials

[1] Pricolo V.E., Ileal pouch-anal anastomosis: the ideal operation for ulcerative colitis and adenomatous polyposis coli? R. I. Med., 1994, 77, 382–384 Search in Google Scholar

[2] Blumberg D., Beck D.E., Surgery for ulcerative colitis, Gastroenterol. Clin. North Am., 2002, 31, 219–235 10.1016/S0889-8553(01)00013-9Search in Google Scholar

[3] Aziz O., Athanasiou T., Fazio V.W., Nicholls R.J., Darzi A.W., Church J., et al., Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis, Br. J. Surg., 2006, 93, 407–417 http://dx.doi.org/10.1002/bjs.527610.1002/bjs.5276Search in Google Scholar PubMed

[4] Keighley M.R., Review article: the management of pouchitis. Aliment. Pharmacol. Ther., 1996, 10, 449–457 http://dx.doi.org/10.1046/j.1365-2036.1996.32174000.x10.1046/j.1365-2036.1996.32174000.xSearch in Google Scholar PubMed

[5] Nicholls R.J., Belliveau P., Neill M., Wilks M., Tabaqchali S., Restorative proctocolectomy with ileal reservoir: a pathophysiological assessment, Gut, 1981, 22, 462–468 http://dx.doi.org/10.1136/gut.22.6.46210.1136/gut.22.6.462Search in Google Scholar PubMed PubMed Central

[6] Zuccaro G.Jr., Fazio V.W., Church J.M., Lavery I.C., Ruderman W.B., Farmer R.G., Pouch ileitis, Dig. Dis. Sci., 1989, 34, 1505–1510 http://dx.doi.org/10.1007/BF0153710110.1007/BF01537101Search in Google Scholar PubMed

[7] Tytgat G.N., van Deventer S.J., Pouchitis, Int. J. Colorectal Dis., 1988, 3, 226–228 http://dx.doi.org/10.1007/BF0166072010.1007/BF01660720Search in Google Scholar PubMed

[8] Simchuk E.J., Thirlby R.C., Risk factors and true incidence of pouchitis in patients after ileal pouchanal anastomoses, World J. Surg., 2000, 24, 851–856 http://dx.doi.org/10.1007/s00268001013610.1007/s002680010136Search in Google Scholar PubMed

[9] Kmiot W.A., Youngs D., Tudor R., Thompson H., Keighley M.R., Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis, Br. J. Surg. 1993, 80, 1445–1449 http://dx.doi.org/10.1002/bjs.180080113210.1002/bjs.1800801132Search in Google Scholar PubMed

[10] Rahimi R., Nikfar S., Rezaie A., Abdollahi M., A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn’s disease, Clin. Ther., 2006, 28, 1983–1988 http://dx.doi.org/10.1016/j.clinthera.2006.12.01210.1016/j.clinthera.2006.12.012Search in Google Scholar PubMed

[11] Rahimi R., Nikfar S., Rezaie A., Abdollahi M., A metaanalysis of antibiotic therapy for active ulcerative colitis, Dig. Dis. Sci., 2007, 52, 2920–2925 http://dx.doi.org/10.1007/s10620-007-9760-110.1007/s10620-007-9760-1Search in Google Scholar PubMed

[12] Baker D.E., Rifaximin: a nonabsorbed oral antibiotic, Rev. Gastroenterol. Disord., 2005, 5, 19–30 Search in Google Scholar

[13] Ewaschuk J.B., Tejpar Q.Z., Soo I., Madsen K., Fedorak R.N., The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease, Curr. Gastroenterol. Rep., 2006, 8, 486–498 http://dx.doi.org/10.1007/s11894-006-0039-z10.1007/s11894-006-0039-zSearch in Google Scholar PubMed

[14] Gionchetti P., Rizzello F., Lammers K.M., Morselli C., Sollazzi L., Davies S., et al., Antibiotics and probiotics in treatment of inflammatory bowel disease, World J. Gastroenterol., 2006, 12, 3306–3313 10.3748/wjg.v12.i21.3306Search in Google Scholar PubMed PubMed Central

[15] Gionchetti P., Rizzello F., Venturi A., Ugolini F., Rossi M., Brigidi P., et al., Antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach, Eur. Rev. Med. Pharmacol. Sci., 1999, 3, 27–30 Search in Google Scholar

[16] Sachar D.B., How do you treat refractory pouchitis and when do you decide to remove the pouch? Inflamm. Bowel Dis., 1998, 4, 165–166 http://dx.doi.org/10.1002/ibd.378004021210.1097/00054725-199805000-00028Search in Google Scholar

[17] Sandborn W.J., McLeod R., Jewell D.P., Medical therapy for induction and maintenance of remission in pouchitis: a systematic review, Inflamm. Bowel Dis. 1999, 5, 33–39 10.1097/00054725-199902000-00005Search in Google Scholar PubMed

[18] Madden M.V., McIntyre A.S., Nicholls R.J., Doubleblind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis, Dig. Dis. Sci., 1994, 39, 1193–1196 http://dx.doi.org/10.1007/BF0209378310.1007/BF02093783Search in Google Scholar PubMed

[19] Sambuelli A., Boerr L., Negreira S., Gil A., Camartino G., Huernos S., et al., Budesonide enema in pouchitis-a double-blind, double-dummy, controlled trial, Aliment. Pharmacol. Ther. 2002, 16, 27–34 http://dx.doi.org/10.1046/j.1365-2036.2002.01139.x10.1046/j.1365-2036.2002.01139.xSearch in Google Scholar PubMed

[20] Shen B., Fazio V., Remzi F., Bennett A., Lopez R., Brzezinski A., et al., Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis, Dis. Col. Rectum., 2007, 50, 498–508 http://dx.doi.org/10.1007/s10350-006-0828-310.1007/s10350-006-0828-3Search in Google Scholar PubMed

[21] Isaacs K.L., Sandler R.S., Abreu M., Picco M.F., Hanauer S.B., Bickston S.J., et al., Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study, Inflamm. Bowel Dis., 2007, 13, 1250–1255 http://dx.doi.org/10.1002/ibd.2018710.1002/ibd.20187Search in Google Scholar PubMed

[22] Shen B., Achkar J.P., Lashner B.A., Ormsby A.H., Remzi F.H., Brzezinski A., et al., A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis, Inflamm. Bowel Dis., 2001, 7, 301–305 http://dx.doi.org/10.1097/00054725-200111000-0000410.1097/00054725-200111000-00004Search in Google Scholar PubMed

[23] Nygaard K., Bergan T., Bjorneklett A., Hoverstad T., Lassen J., Aase S., Topical metronidazole treatment in pouchitis, Scand. J. Gastroenterol., 1994, 29, 462–467 http://dx.doi.org/10.3109/0036552940909683910.3109/00365529409096839Search in Google Scholar PubMed

[24] Egger M., Smith G.D., Phillips A.N., Meta-analysis: principles and procedures, B. M. J., 1997, 315, 1533–1537 10.1136/bmj.315.7121.1533Search in Google Scholar

[25] Abdelrazeq A.S., Kelly S.M., Lund J.N., Leveson S.H., Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis, Colorectal Dis., 2005, 7, 182–186 http://dx.doi.org/10.1111/j.1463-1318.2004.00746.x10.1111/j.1463-1318.2004.00746.xSearch in Google Scholar

[26] Abitbol V., Chaussade S., Pouchitis after ileal pouchanal anastomosis. Gastroenterol. Clin. Biol., 1997, 21, 299–304 Search in Google Scholar

[27] Becker J.M., Stucchi A.F., Bryant D.E., How do you treat refractory pouchitis and when do you decide to remove the pouch? Inflamm. Bowel Dis., 1998, 4, 167–169 http://dx.doi.org/10.1002/ibd.378004021310.1097/00054725-199805000-00029Search in Google Scholar

[28] Gerard L., Garey K.W., DuPont H.L., Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections, Expert. Rev. Anti. Infect. Ther., 2005, 3, 201–211 http://dx.doi.org/10.1586/14787210.3.2.20110.1586/14787210.3.2.201Search in Google Scholar

[29] Gionchetti P., Amadini C., Rizzello F., Venturi A., Poggioli G., Campieri M., Diagnosis and treatment of pouchitis, Best Pract. Res. Clin. Gastroenterol., 2003, 17, 75–87 http://dx.doi.org/10.1053/bega.2002.034810.1053/bega.2002.0348Search in Google Scholar

[30] Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I.C., et al., Four-week openlabel trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis, Aliment. Pharmacol. Ther., 2002, 16, 909–917 http://dx.doi.org/10.1046/j.1365-2036.2002.01203.x10.1046/j.1365-2036.2002.01203.xSearch in Google Scholar

[31] Madiba T.E., Bartolo D.C., Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. J. R. Coll. Surg. Edinb., 2001, 46, 334–337 Search in Google Scholar

[32] Gionchetti P., Rizzello F., Venturi A., Ugolini F., Rossi M., Brigidi P., et al., Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis, Aliment. Pharmacol. Ther., 1999, 13, 713–718 http://dx.doi.org/10.1046/j.1365-2036.1999.00553.x10.1046/j.1365-2036.1999.00553.xSearch in Google Scholar

[33] Shen B., Remzi F.H., Lopez A.R., Queener E., Rifaximin for maintenance therapy in antibioticdependent pouchitis, BMC Gastroenterol., 2008, 23, 26 http://dx.doi.org/10.1186/1471-230X-8-2610.1186/1471-230X-8-26Search in Google Scholar

[34] Gionchetti P., Rizzello F., Helwig U., Venturi A., Lammers K.M., Brigidi P., et al., Prophylaxis of pouchitis onset with probiotic therapy: a doubleblind, placebo-controlled trial, Gastroenterology, 2003, 124, 1202–1209 http://dx.doi.org/10.1016/S0016-5085(03)00171-910.1016/S0016-5085(03)00171-9Search in Google Scholar

[35] Elahi B., Nikfar S., Derakhshani S., Vafaie M., Abdollahi M., Benefit of probiotics in the control of pouchitis in patients underwent ileal pouch anal anastomosis operation; A meta-analysis of controlled clinical trials, Dig. Dis. Sci., 2007, 53, 1278–1284 http://dx.doi.org/10.1007/s10620-007-0006-z10.1007/s10620-007-0006-zSearch in Google Scholar PubMed

[36] Sambuelli A., Boerr L., Negreira S., Gil A., Camartino G., Huernos S., et al., Budesonide enema in pouchitis—a double-blind, double-dummy, controlled trial, Aliment. Pharmacol. Ther., 2002, 16, 27–34 http://dx.doi.org/10.1046/j.1365-2036.2002.01139.x10.1046/j.1365-2036.2002.01139.xSearch in Google Scholar

[37] Gionchetti P., Rizzello F., Venturi A., Ferretti M., Brignola C., Peruzzo S., et al., Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis, Aliment. Pharmacol. Ther., 1997, 11, 673–678 http://dx.doi.org/10.1046/j.1365-2036.1997.00217.x10.1046/j.1365-2036.1997.00217.xSearch in Google Scholar

[38] Wischmeyer P., Pemberton J.H., Phillips S.F., Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study, Mayo Clin. Proc., 1993, 68, 978–981 10.1016/S0025-6196(12)62270-8Search in Google Scholar

[39] Levin K.E., Pemberton J.H., Phillips S.F., Zinsmeister A.R., Pezim M.E., Role of oxygen free radicals in the etiology of pouchitis. Dis. Colon Rectum, 1992, 35, 452–456 http://dx.doi.org/10.1007/BF0204940110.1007/BF02049401Search in Google Scholar PubMed

[40] Hurst R.D., Molinari M., Chung T.P., Rubin M., Michelassi F., Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy, Arch. Surg., 1996, 131, 497–500 10.1001/archsurg.1996.01430170043007Search in Google Scholar PubMed

[41] Rahimi R., Nikfar S., Rezaie A., Abdollahi M., A metaanalysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: evidence for prevention of disease relapse and maintenance of remission, Arch. Med. Sci. 2008, 4, 185–190 Search in Google Scholar

[42] Rahimi R., Nikfar S., Rahimi F., Elahi B., Derakhshani S., Vafaie M., et al., A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn’s disease, Dig. Dis. Sci., 2008, 53, 2524–2531 http://dx.doi.org/10.1007/s10620-007-0171-010.1007/s10620-007-0171-0Search in Google Scholar PubMed

[43] Nikfar S., Rahimi R., Rahimi F., Derakhshani S., Abdollahi M., Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials, Dis. Col. Rectum, 2008, 51, 1775–1780 http://dx.doi.org/10.1007/s10350-008-9335-z10.1007/s10350-008-9335-zSearch in Google Scholar PubMed

[44] Fric P., Probiotics and prebiotics; resistance of a therapeutic principle, Cent. Eur. J. Med., 2007, 2, 237–270. http://dx.doi.org/10.2478/s11536-007-0031-510.2478/s11536-007-0031-5Search in Google Scholar

[45] Rahimi R., Nikfar S., Abdollahi M., Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: A meta-analysis of randomized controlled trials, Arch. Med. Sci., 2008, 4, 71–76 Search in Google Scholar

[46] Talley N.J., Newer antidepressants in irritable bowel syndrome: what is the evidence? Arch. Med. Sci., 2008, 4, 77–78. Search in Google Scholar

[47] Rahimi R., Nikfar S., Abdollahi M., Meta-analysis technique confirms the effectiveness of anti-TNF-a in the management of active ulcerative colitis when administered in combination with corticosteroids, Med. Sci. Monit., 2007, 13, PI13–PI18 Search in Google Scholar

[48] Rahimi, R., Nikfar, S., Abdollahi M., Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn’s disease? A systematic meta-analysis of controlled clinical trials, Biomed. Pharmacother., 2007, 61, 75–80 http://dx.doi.org/10.1016/j.biopha.2006.06.02210.1016/j.biopha.2006.06.022Search in Google Scholar PubMed

[49] Hosseini-Tabatabaei A., Abdollahi M., Potassium channel openers and improvement of toxic stress: do they have role in the management of inflammatory bowel disease? Inflamm. Allergy Drug Targets, 2008, 7, 129–135 http://dx.doi.org/10.2174/18715280878574816410.2174/187152808785748164Search in Google Scholar PubMed

[50] Rezaie A., Parker R.D., Abdollahi M., Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig. Dis. Sci., 2007, 52, 2015–2021 http://dx.doi.org/10.1007/s10620-006-9622-210.1007/s10620-006-9622-2Search in Google Scholar PubMed